Anthony Barsotti, Ph.D.
Senior Director, Preclinical Pharmacology
Anthony Barsotti, Ph.D., is a Senior Director, Preclinical Pharmacology, Deerfield Discovery and Development, and joined the Firm in 2020. Prior to Deerfield, Dr. Barsotti served as Director of Target Discovery Biology at Inzen Therapeutics. Before Inzen, he served as a Principal Scientist (Molecular Signaling) at Kadmon Corporation. He began his career as a Post-Doctoral Fellow at Pfizer in the Oncology Research Unit. Dr. Barsotti holds a B.A. in Biochemistry from University of Pennsylvania and a Ph.D. in Biological Sciences from Columbia University.